tweetindex
IT

Oncology Tube ✓

@oncologytube · Temecula, CA · joined 30 Sep 2009

Stay Up To Date with our Newsletter: https://t.co/BQxZ2gkon8 Delivering top-quality multimedia to oncologists, hematologists, and cancer pros!

17 098Followers
799Following
141 683Posts total
3KViews on collected posts

Ultimi post

MATTERHORN final OS — 22% reduction in risk of death; 3-y OS 69% vs 62%. Full data: https://t.co/q3tbnDroSk 586 views · 4 likes · 1 reposts · 3 replies Open on X →
WATCH: MATTERHORN final OS — Imfinzi + FLOT in resectable gastric/GEJ 🩺 👉 https://t.co/q3tbnDroSk 🔹 Perioperative durvalumab + FLOT vs placebo + FLOT (Lancet) 🔹 22% reduction in risk of death; median FU 43 mo; median OS NR both arms 🔹 3-year OS 69% vs 62% — EFS already https://t.
621 views · 8 likes · 1 reposts · 4 replies Open on X →
WATCH: Etentamig CERVINO — ORR 74% in triple-class RRMM 🩸 👉 https://t.co/v7JMayFQD5 🔹 Investigational BCMA×CD3 BiTE (ABBV-383) vs SAT (N=393) 🔹 ORR 74.0% vs 45.7%; PFS HR 0.40 (both P<0.0001) 🔹 Single step-up then Q4W; CRS 28% mostly low-grade — not FDA-approved; full data https:
687 views · 5 likes · 2 reposts · 5 replies Open on X →
ARROS-1’s zidesamtinib showed a 44% ORR, with DOR ≥6 months in 82% of responders. Full data: https://t.co/QCOd9YSZMi 419 views · 0 likes · 1 reposts · 0 replies Open on X →
WATCH: Jideytro FDA — ROS1+ NSCLC after prior TKI (ARROS-1) 🫁 👉 https://t.co/QCOd9YSZMi 🔹 Zidesamtinib approved after ≥1 prior ROS1 TKI 🔹 ARROS-1 n=117: ORR 44%; DOR ≥6 mo in 82% of responders 🔹 100 mg PO daily — not interchangeable with taletrectinib Full data on https://t.co/yg
646 views · 4 likes · 2 reposts · 6 replies Open on X →

Rispetto ad account della stessa dimensione

5 post degli ultimi 90 giorni, accanto alla fascia di 10K–100K follower. esattamente sulla mediana della sua fascia di follower.

Visualizzazioni mediane621questo account924mediana per 10K–100K
Copertura, %3.63%questo account3.62%mediana per 10K–100K
Interazione, %1.75%questo account1.52%mediana per 10K–100K
MetricaQuesto accountMediana per 10K–100KRapporto
Visualizzazioni mediane per post6219240.67×
Copertura (visualizzazioni ÷ follower)3.63%3.62%1.00×
Tasso di interazione1.75%1.52%1.15×

Altri account di questa fascia →   Confronta con un altro account →   Come sono costruiti questi parametri →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

64610 Sep
419
687
62111 Sep
586

Last 5 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

1.86%10 Sep
0.24%
1.75%
2.09%11 Sep
1.37%

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.52%.

What the audience does

Likes45.7%21 in total
Reposts15.2%7 in total
Replies39.1%18 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Account simili